METHOD FOR DRUG DISCOVERY USING FRAGMENT ASSEMBLY

Information

  • Research Project
  • 6345558
  • ApplicationId
    6345558
  • Core Project Number
    R43CA085141
  • Full Project Number
    5R43CA085141-02
  • Serial Number
    85141
  • FOA Number
    PAR-98-073
  • Sub Project Id
  • Project Start Date
    7/1/1999 - 25 years ago
  • Project End Date
    2/28/2001 - 23 years ago
  • Program Officer Name
    LEES, ROBERT
  • Budget Start Date
    9/1/2000 - 24 years ago
  • Budget End Date
    2/28/2001 - 23 years ago
  • Fiscal Year
    2000
  • Support Year
    2
  • Suffix
  • Award Notice Date
    8/30/2000 - 24 years ago

METHOD FOR DRUG DISCOVERY USING FRAGMENT ASSEMBLY

DESCRIPTION (Adapted from the application): The goal of this project is to validate a new method for drug-lead discovery that relies on cascaded multi-step selection of small chemical groups to construct larger molecules having high affinity for a protein target. This method increases efficiency over combinatorial chemistry in executing the selection before, rather than after, chemical synthesis. This technology will be developed using thymidylate synthase, a validated target for anti-cancer and anti-proliferative agents. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    109200
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:109200\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SUNESIS PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    SOUTH SAN FRANCISCO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    94080
  • Organization District
    UNITED STATES